Xeris Biopharma Holdings, Inc.

DB:2B30 Stock Report

Market Cap: €242.5m

Xeris Biopharma Holdings Ownership

Who are the major shareholders and have insiders been buying or selling?


Recent Insider Transactions

DB:2B30 Recent Insider Transactions by Companies or Individuals
DateValueNameEntityRoleSharesMax Price
14 Mar 24Buy€8,924John SchmidIndividual4,500€1.98
27 Nov 23Buy€9,239Jeffrey ShermanIndividual5,400€1.71
20 Nov 23Buy€49,899Steven PieperIndividual28,000€1.78
20 Nov 23Buy€9,097Dawn HalkuffIndividual5,410€1.68
17 Nov 23Buy€46,297John ShannonIndividual30,769€1.50
16 Nov 23Buy€9,036John SchmidIndividual6,500€1.39
14 Nov 23Buy€9,267Marla PerskyIndividual6,370€1.45
09 Aug 23Buy€21,672Paul EdickIndividual10,000€2.17

Insider Trading Volume

Insider Buying: 2B30 insiders have bought more shares than they have sold in the past 3 months.


Ownership Breakdown

What is the ownership structure of 2B30?
Owner TypeNumber of SharesOwnership Percentage
Private Companies27,8480.0188%
Individual Insiders6,233,1984.2%
Institutions62,151,16341.9%
General Public79,841,40653.9%

Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 8%.


Top Shareholders

Top 25 shareholders own 39.98% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
6.75%
BlackRock, Inc.
10,011,391€16.4m6.8%no data
4.78%
The Vanguard Group, Inc.
7,086,345€11.6m0.86%no data
4%
Stonepine Capital Management LLC
5,937,000€9.7m0.37%4.94%
3.81%
Caxton Associates LP
5,641,920€9.2m0%0.48%
2.6%
BioImpact Capital LLC
3,847,232€6.3m-3.53%1.42%
2.04%
Medical Strategy GmbH, Asset Management Arm
3,028,755€5.0m-2.46%0.31%
1.95%
Geode Capital Management, LLC
2,892,077€4.7m4.28%no data
1.9%
Rosalind Advisors, Inc.
2,820,170€4.6m-20.4%4.52%
1.84%
State Street Global Advisors, Inc.
2,724,126€4.5m5.99%no data
1.1%
Steven Pieper
1,626,912€2.7m38.2%no data
1.09%
Paul Edick
1,621,494€2.7m47.9%no data
1.04%
Millennium Management LLC
1,547,955€2.5m-31.9%no data
0.93%
Renaissance Technologies LLC
1,381,640€2.3m35.2%no data
0.81%
Morgan Stanley, Investment Banking and Brokerage Investments
1,205,746€2.0m91.9%no data
0.79%
Northern Trust Global Investments
1,165,363€1.9m1.76%no data
0.71%
D. E. Shaw & Co., L.P.
1,054,610€1.7m20.5%no data
0.71%
Redmile Group, LLC
1,046,587€1.7m0%0.08%
0.56%
John Shannon
825,242€1.4m86.8%no data
0.48%
John Johnson
708,912€1.2m43.7%no data
0.38%
Invenomic Capital Management LP
568,619€930.2k0%0.13%
0.37%
Tudor Investment Corporation
553,411€905.3k-13.7%0.01%
0.36%
Steven Prestrelski
536,447€877.6k0%no data
0.35%
Columbia Management Investment Advisers, LLC
520,121€850.9k-11.5%no data
0.33%
Beth Hecht
496,635€812.4k199%no data
0.28%
Teachers Insurance and Annuity Association-College Retirement Equities Fund
419,567€686.4k-41.1%no data
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.